This study examines the diversity of superantigen gene profiles between and within emm-genotypes of 92 clinical group A streptococcal isolates (30 STSS, 24 sepsis, 25 erysipelas, and 12 tonsillitis) collected in Sweden between 1986 and 2001. The emm-genotype and the distribution of smeZ, speG, speJ, speA, speC, speH, speI, speK/L, speL/M, speM, and ssa genes, and the smeZ allelic variant were determined using PCR and DNA sequencing. Forty-five emm1 isolates revealed 10 superantigen gene profiles. One profile dominated and was identified in 22 isolates collected over 14 years. The results indicate that a selective advantage maintained this genotype in circulation. The superantigen content among the emm1 isolates ranged from three to seven, with smeZ-1, speG, and speA present in all but one profile. The 47 isolates of 27 other emm-genotypes exhibited 29 superantigen gene profiles. Thus, the distribution of superantigen genes was highly variable within isolates regardless of emm-genotype. Two novel emm1 subtypes and 14 novel smeZ allelic variants were identified. The 22 smeZ alleles were generally linked to the emm-genotype. The results of the investigation show that superantigen gene profiling is useful for tracking spread of clones in the community.
Introduction
Group A Streptococcus (GAS) is a strict human pathogen; clinical manifestation varies from noninvasive diseases, including tonsillitis and erysipelas, to invasive diseases, such as sepsis, streptococcal toxic shock syndrome (STSS), and necrotizing fasciitis (Efstratiou, 2000) . M-proteins and superantigens are important virulence factors in GAS. M-proteins are associated with the cell wall; they promote bacterial adhesion to human epithelial cells and mediate resistance to phagocytosis (Bisno et al., 2003) . The highly variable N-terminal region of the M-protein allows typing of GAS isolates. To date, more than 190 types of the M-protein gene (emm) have been identified in GAS, encompassing over 800 subtypes (http://www.cdc.gov/ncidod/biotech/strep/ strepblast.htm). Superantigens are a group of secreted proteins that unspecifically activate human T-cells by crosslinking to the major histocompatibility complex (MHC) class II and to the T-cell receptor (TCR). This causes massive activation of T-cells and leads to the release of large amounts of cytokines, a characteristic of patients with STSS (NorrbyTeglund et al., 2000 (NorrbyTeglund et al., , 2001 Sriskandan et al., 2007) .
Eleven distinct superantigens have been identified in GAS isolates, three chromosomally encoded (speG, speJ, and smeZ) and eight prophage associated (speA, speC, speH, speI, speK/L, speL/M, speM, and ssa) (Nakagawa et al., 2003) . Superantigens differ in their binding specificity to both the TCR Vb chains and to the MHC class II proteins; it has been reported that the T-cell response mounted by individual superantigens differs (Proft & Fraser, 2007; Sriskandan et al., 2007) . Genome sequencing of GAS strains and PCR analysis of clinical isolates has shown differences in superantigen gene content between GAS of different emm-genotypes (Ferretti et al., 2001; Beres et al., 2002; Smoot et al., 2002; Nakagawa et al., 2003; Schmitz et al., 2003; Green et al., 2005; Rivera et al., 2006; Lintges et al., 2007) .
SmeZ is the most potent streptococcal superantigen, in particular, the SmeZ-2 allelic variant (Proft et al., 1999 Unnikrishnan et al., 2002; Proft & Fraser, 2007) . The high virulence potential of SmeZ in STSS has been demonstrated by both in vitro and in vivo studies. Unnikrishnan et al. (2002) showed that disruption of smeZ in a GAS isolate led to abrogated mitogenic responses in human cells and a complete inability to elicit cytokine production from human cells, despite the presence of other superantigen genes. Studies of the neutralization capacity of individual superantigens in acute and convalescent serum from STSS patients detected serum conversion against SmeZ (Proft et al., 2003a; Yang et al., 2005) . Differences in the level of individual immune response with respect to the neutralization capacity of the mitogenic activity elicited by 11 recombinant SmeZ allelic variants were detected when sera from healthy blood donors were tested .
During the worldwide GAS epidemic at the end of the 1980s, isolates of the T1M1 emm-genotypes were found to dominate, but M3 isolates were also common (Stromberg et al., 1991; Lamagni et al., 2005) . In recent years, a broad spectrum of emm-genotypes has been isolated from patients with invasive diseases; however, globally, isolates of emm1 are still among the most frequently reported emm-genotype associated with invasive GAS infections (Ho et al., 2003; Li et al., 2003; Ekelund et al., 2005a; Rogers et al., 2007; Wahl et al., 2007; Luca-Harari et al., 2008) . The aim of this study was to examine the superantigen gene profile and the smeZ allelic variant in 45 emm1 GAS isolates, and 47 GAS isolates of other emm-genotypes collected in Sweden between 1986 and 2001. The objective of the study was to elucidate whether diversity in superantigen gene profile among GAS allows identification of several clones among isolates of the same emm-genotype.
Materials and methods

Clinical isolates
This study evaluated 92 clinical GAS isolates collected from various places in Sweden between 1986 and 2001. Inclusion criteria were the availability of the infecting isolate, acute and/or convalescent sera as well as data concerning the patient diagnosis. Results from the analysis of the immune responses against the infecting isolate have been published by Maripuu et al. (2007) . Twenty-eight emm-genotypes were present in the material and, of these, eight were represented by two or more isolates (emm1, emm2, emm4, emm8, emm12, emm28, emm66, and emm75). The isolates were collected from patients with noninvasive and invasive infections: 30 had STSS, 24 sepsis, 25 erysipelas, and 12 tonsillitis. For one isolate, the patient's symptom was not recorded.
emm -Typing
emm-Type identification, by DNA sequencing, was performed according to the Centers for Disease Control and Prevention (CDC) guidelines, available at http:// www.cdc.gov/ncidod/biotech/strep/strepindex.html, with minor modifications. Briefly, DNA was purified using a DNeasy Tissue Kit (Qiagen Nordic, Stockholm, Sweden) and resolved in dH 2 O. The PCR product was amplified with CDC primers 1 and 2, and primers MF2 and MR1 at a concentration of 50 pmol mL À1 , then purified using a QIAquick PCR purification kit (Qiagen Nordic), and sequenced with the CDC primer emmseq2. The emm sequence database at CDC was searched for homologues of the sequences obtained.
Gene detection
The presence of 13 GAS genes was determined by PCR, using c. 50 ng DNA, 0.4 mM of each forward and reverse primer (see Supporting Information, Table S1 ) for 45 s, and extension at 72 1C for 30 s, followed by a further extension at 72 1C for 7 min. As positive control for PCR amplification of respective superantigen gene, GAS isolates from which the individual superantigen genes had previously been amplified and confirmed by DNA sequencing were used. The PCR-positive controls and the smeZ genes were sequenced with the primers listed in Table S1 . For clarity, a double nomenclature for the speK/L and the speL/M genes were used. speK/L corresponds to the speK gene identified in the complete genome analysis of an M3 strain, and to the speL gene identified in a temperate phage NIHI from an M3 strain Ikebe et al., 2002; Proft & Fraser, 2007) . speL/M corresponds to the speL gene identified in the complete genome analysis of an M18 strain, and to the speM gene identified in an M80 strain (Smoot et al., 2002; Proft et al., 2003a, b; Proft & Fraser, 2007) . The DNA sequences were confirmed by analysing samples in triplicate. The accession numbers for the novel smeZ alleles are AY647149-AY647153, EF529452-EF529459, and EU380242. Southern blot analysis was performed according to standard methods (Sambrook & Russell, 2001) . Briefly, 5 mg DNA from each isolate was digested with EcoRI, when screening for the speH, speI, and speL/M genes, and HindIII, when screening for the speG gene. The DNA was separated on 0.7% agarose gel, capillary transferred onto a blotting membrane (Bio-Rad, Sundbyberg, Sweden), and crosslinked by UV light. Probe templates were amplified using primers indicated in Table S1 and labelled with 32 P dCTP using Rediprime TM RPN 1633 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). Hybridization was performed at 68 1C and washed at 68 1C in buffers provided by the manufacturer (Bio-Rad).
Statistical analysis
The proportions of individual superantigen genes between different superantigen gene profile categories were analysed using two proportion tests. The analyses were performed using MINITAB 14.3 (Minitab, Coventry, UK).
Structural modelling
The predicted protein structures for the novel smeZ-26 and smeZ-28 alleles were determined using SWISS-MODEL, a structure homology-modelling server, which can be found at http://www.swissmodel.expasy.org/. The highest similarity score was obtained using SmeZ-2 1ET6 as a template. The molecular models thus acquired were rendered using the Swiss PDB-viewer at http://www.expasy.ch/spdbv/ and Pov-Ray at http://www.povray.org.
Results
Superantigen gene profiles among clinical GAS isolates
Among the 92 clinical GAS isolates, 28 emm-genotypes and 38 different superantigen gene profiles were identified (Table 1 ). The differences in superantigen gene distribution among the 38 profiles were mainly due to the presence or absence of the prophage-associated genes, but variations due to chromosomally encoded superantigen genes were also detected. The 38 profiles identified contained between two and seven superantigen genes, with a median of four genes per profile. Two profiles harboured only two superantigen genes. Profile Z detected in an STSS isolate, and profile AA detected in an erysipelas isolate harboured speG and speJ, and speG and speK/L, respectively. The three chromosomally encoded genes (smeZ, speG, and speJ) occurred at a median of two. The eight phage-associated superantigen genes (speA, speC, speH, speI, speK/L, speL/M, speM, and ssa) were also present at a median of two. The most common superantigen genes in the profiles were smeZ and speG, present in 84% and 100%, respectively ( Table 2 ). The least common superantigen genes were speL/M and ssa, found in 11% and 13% of the profiles, respectively. No dominant superantigen gene profile was found among invasive isolates compared with noninvasive isolates.
Comparison of superantigen gene profile diversity within and between emm -genotypes emm1 was the most common emm-genotype in the study, represented by 45 isolates. Two novel subtypes, emm1.41 and emm1.42, and 10 different superantigen gene profiles were detected among the emm1 isolates (Table 1 ). The remaining 47 isolates represented 27 different emm-genotypes and 29 different superantigen gene profiles. Isolates of different emm-genotypes generally encoded different profiles, but profiles D, K, S, and AD were detected in more than one emm-genotype.
Among the 45 emm1 isolates no correlation was found between the superantigen gene profile and the year of isolation (Table 1) . Of the 10 emm1-associated profiles, nine were observed in GAS isolated in 1989. The dominating profile C was represented by 21 emm1.0 isolates and one emm1.41 isolate, collected between 1988 and 2001. This profile contained the smeZ-1, speG, speJ, and speA genes and was identified in 13 of the 30 STSS isolates. A significantly higher proportion of the superantigen gene profiles within emm1 isolates harboured the speA and the smeZ-1 gene compared with profiles within other emm-genotypes ( Table 2) .
Distribution of superantigen genes among the profiles
All emm1 superantigen gene profiles contained the smeZ-1, speG, and speA genes, with the exception of profile D1, detected in a sepsis isolate and lacking the speA gene (Table  1 ). The speJ and speC genes were detected in 70% and 60% of the emm1 profiles, respectively (Table 2) . A high percentage of the 29 profiles represented by emm-genotypes other than emm1 contained the smeZ, speG, and speC genes: 79%, 100%, and 62%, respectively. The speA and the speJ genes, however, were only detected in 17% and 31% of the profiles, respectively. Only two of the 10 emm1 profiles harboured the speH, speI, and speM genes, one profile contained the speK/L gene, while none of the emm1 isolates encoded the speL/M or the ssa genes (Table 1) . Among isolates belonging to other emm-genotypes, the speH, speI, and speM genes were found in 38%, 31%, and 24%, respectively ( Table 2) . The speK/L, speL/M, and ssa genes were present in 31%, 14%, and 17%, of the profiles, respectively. It has been reported that the speI, speH, and speL/M, speM gene pairs are located in tandem on separated phages (Ferretti et al., 2001; Smoot et al., 2002) . In the present study, speI and speH were detected as single genes in 11% and 16%, respectively, of the 38 superantigen gene profiles, and speM in 13%.
Allelic variants of smeZ
In the present study, 22 allelic variants of the smeZ gene were detected, including 14 novel variants (smeZ-26-30 and 40-48) ( Table 1) . In general, a single smeZ allelic variant was linked to a specific emm-genotype. However, different smeZ allelic variants, smeZ-3 and smeZ-30, were detected among two emm2 isolates and a further two emm2 isolates lacked the smeZ gene. The same smeZ allelic variant could be detected in isolates of different emm-genotypes. The smeZ-1 allele was present in isolates of emm1 and emm6, the smeZ-3 in emm2 and emm12 isolates, and the smeZ-27 in emm8 and The emm-subtype was determined for isolates of emm1, emm2, emm8, emm28, emm41, emm66, and emm89.
w All isolates harbored the cysteine protease gene speB and the speF gene encoding the mitogenic factor (DNAses), with the exception of the emm82 isolate, which lacked speF.
z For the isolates with one of the genes detected in the gene pairs speH, speI, and speL/M and speM, the negative PCR result were confirmed with Southern blot analysis.
‰
The superantigen gene profiles with the same superantigen gene content but with different smeZ alleles are numbered according to the smeZ-allele. The diagnosis of the patient was unknown for the isolate representing superantigen gene profile L.
emm, M-protein-coding gene; smeZ, streptococcal mitogenic exotoxin; spe, streptococcal pyrogenic exotoxin; ssa, streptococcal superantigen; STSS, streptococcal toxic shock syndrome. The novel smeZ alleles identified in the present study revealed nonsynonymous substitutions in the predicted sequence. This occurred mainly in mosaic regions identified previously, which are thought to be exposed on the surface but not located within known receptor-binding regions. The variability in the amino acid composition of SmeZ noted exemplifies the antigenic selection of novel variants in relation to immunity in the population generated by intergenic recombination. However, previous studies have shown that these polymorphisms do not affect the Vb4 or the Vb8 specificity and the mitogenic activity of the protein remains Sundberg et al., 2002) . The novel variants smeZ-26 and smeZ-28 identified in the current study contained a three amino acid deletion in positions 43-45. Structural modelling showed that the deletion shortens one of the b-sheets in the N-terminal domain of the protein.
These positions correspond to a putative functional domain of the SmeZ-2 protein, b strands two and three (Arcus et al., 2000) . The loop between b strands two and three has been shown to be part of the T-cell-binding site (Swaminathan et al., 1992; Arcus et al., 2000) . The novel smeZ-alleles 26, 27, 29, and 45 contained single substitutions in the amino acid domain 150-160, a domain found to be structurally conserved among classical superantigens. This domain has been suggested to mediate binding of costimulatory molecules for T-cell activation (Arad et al., 2000) . The possible effect of the deletions and the amino acid substitutions in the novel variants on the immune receptor specificity and mitogenic activity warrants further studies.
Discussion
The screening of 92 clinical GAS isolates collected in Sweden between 1986 and 2001 revealed extensive differences in superantigen gene content both between and within isolates of the same emm-genotype. Only four superantigen gene profiles were found to be common among isolates of more than one emm-genotype. Earlier studies of GAS isolates have reported diversity in the superantigen gene content of isolates of different emm-genotypes, but within isolates of the same emm-genotype only low levels of diversity have been reported. It should be noted that in most other studies the screening did not include all 11 superantigen genes (Schmitz et al., 2003; Vlaminckx et al., 2003; Rivera et al., 2006) . Schmitz et al. (2003) suggested that the emmgenotype might function as a barrier for the superantigen genes. In the current study, some superantigen genes were more common among the profiles found in isolates of a certain emm-genotype, but we believe this might be explained by a close genetic relationship between isolates harbouring these profiles. During the past 20 years, isolates of the emm1 genotype have dominated among invasive GAS isolated from around the world and high genetic similarities have been reported for these isolates (Stromberg et al., 1991; Norgren et al., 1992; Colman et al., 1993; Muotiala et al., 1997; Mascini et al., 1999; Chatellier et al., 2000; Vlaminckx et al., 2003; Lamagni et al., 2005) . In our study, we found 10 different superantigen gene profiles among the 45 emm1 isolates, encoding three to seven superantigen genes. These genetic differences were seen even among GAS isolated during a single year. Thus, in relation to their superantigen gene profile, these isolates can be considered a rather genetically heterogeneous group. A similar high diversity in the distribution of superantigen genes was identified among isolates belonging to other emm-genotypes. Thus, a wide genotypic diversity in superantigen gene content within a single GAS emm-genotype isolated during a restricted time period seems to be the general trend. In a previous report by Ekelund et al. (2005b) five superantigen genes were screened for and reported low superantigen genotypic variability among emm1 isolates. A limited number of superantigen gene profiles were also found when the distribution of six superantigen genes was determined among isolates of different emm-genotypes (Curtis et al., 2007) . Our results stress the importance of screening for all known superantigen genes when investigating genetic diversity in epidemiological studies. Ã Profile D was present in both emm1 isolates and in isolates of other emm-genotypes (emm28 and emm68).
w Significant difference in superantigen gene distribution when comparing profiles of emm1 isolates to that of profiles in other emm-genotypes (P o 0.001). emm, M-protein-coding gene; smeZ, streptococcal mitogenic exotoxin; spe, streptococcal pyrogenic exotoxin; ssa, streptococcal superantigen.
The genetic diversity among superantigen gene profiles was most common for the prophage-associated genes, both among the emm1 isolates and the isolates of other emmgenotypes. The second most frequently detected superantigen gene profile among isolates of emm1 only differed from the most prevalent emm1 profile by the presence of the prophage-associated speC gene. The addition or loss of one to four phage genes constitutes the main profile difference between isolates of the same emm-genotype and displays the common exchange of phage-associated virulence genes shown to exist between GAS isolates (Banks et al., 2002; Nakagawa et al., 2003) . An example of ongoing genetic diversification within the prophage genomes is our detection of speH and speI as single genes in some of the isolates. These genes have been reported previously to be located in tandem on phage 370.2 in the emm1 strain SF370 (Ferretti et al., 2001) . Similar results were found for the speM and speL/M genes, previously reported to be located in tandem on phage phi speLM in the emm18 strain MGAS8232 (Smoot et al., 2002) .
Although the emm1 isolates exhibited high diversity in superantigen gene content, one dominant superantigen gene profile, profile C, was recorded, occurring in 22 of the 45 emm1 isolates. This profile was found in isolates collected over a period of 14 years and has also been identified as the predominant profile in earlier screenings of emm1 isolates from Europe (Schmitz et al., 2003; Vlaminckx et al., 2003; Ekelund et al., 2005b; Rivera et al., 2006) . Thus, even though half of the emm1 isolates exhibited rather significant differences in superantigen gene profile, one stable genotype of emm1 remained circulating in the population. The prevalence of stable genotypes was also seen among isolates belonging to other emm-genotypes and exemplified by emm28 and profile D16. This genotype has been shown previously to dominate among emm28 isolates in a study by Schmitz et al. (2003) , except that, in their study, the profile lacked the smeZ gene. However, smeZ was present at a remarkably low frequency among all of the 239 invasive isolates screened in their study; this brings into question the detection method they used for this particular gene. The dominant superantigen gene profiles among emm1 and emm28 isolates were also detected in isolates of other subtypes and emm-genotypes; this might indicate a selection pressure favouring these particular profiles.
The smeZ gene, together with speG, was the most frequently occurring superantigen in our study as well as in other studies of GAS isolates collected worldwide Rivera et al., 2006; Rogers et al., 2007) . In the current study, 14 new allelic variants of the smeZ gene and two new emm1-subtypes were identified. Today, a total of 47 smeZ alleles have been reported, including the 14 novel variants reported herein; this makes smeZ the superantigen with the highest allelic variation (Kamezawa et al., 1997; Proft et al., 1999 Proft et al., , 2000 Proft et al., , 2003 Yang et al., 2005; Rivera et al., 2006) . Two earlier studies have proposed linkage equilibrium between the emm-genotype and the smeZ allele of the GAS isolates Rivera et al., 2006) . Our data support the suggestion of a link between the emm-genotype and the smeZ allele. Despite the presence of diverse superantigen gene profiles within emm-genotypes, we found only one exception to the absence of allelic variation in smeZ within the same emm-genotype. Two of the four emm2 isolates lacked the smeZ gene and the other two encoded different smeZ alleles. However, isolates of different emmgenotypes were found to encode the same smeZ allele. The high degree of polymorphism detected in the emm and smeZ genes among GAS isolates mirrors the high immunogenic pressure and the importance of these two genes for the virulence of GAS isolates.
A common feature of the STSS profiles in the present study was the high frequency of the smeZ-1 allelic variant and the speA genes. This finding is partially explained by the high frequency of emm1 among the STSS isolates, and the correlation between speA and smeZ-1 genes and emm1 profiles. The speA gene has been identified previously as a virulence factor associated with invasive disease (Musser et al., 1991; Eriksson et al., 1999; Beres et al., 2006) . Beres et al. (2006) detected a strong association between the persistence of M3 GAS epidemics and the presence of the speA gene among the isolates. An association between speC and invasive disease was reported in studies during the early 1990s in collections of isolates dominated by GAS of M1 serotype (Demers et al., 1993; Leggiadro et al., 1993) . In the present study, with material from that time period, no correlation between the distributions of speC in the superantigen gene profiles among the different emm-genotype or severity of disease was noted.
In the current study, high diversity in superantigen gene profiles both within and between emm-genotypes was found and shows that superantigen gene profiling might be useful in tracking the spread of clones in the community and nosocomial outbreaks. One emm1 clone with a stable superantigen gene profile was collected over a period of 14 years, suggesting the selection of a successful profile, although other traits might also contribute to the prevalence of the clone.
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